Mindfulness Meditation in Bone Marrow Transplantation
1 other identifier
interventional
241
1 country
3
Brief Summary
The main purpose of this study is to examine techniques to help patients cope better with the stem cell/bone marrow transplant procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Apr 2005
Longer than P75 for phase_2
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedNovember 28, 2013
November 1, 2013
4.8 years
September 9, 2005
November 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychological functioning
1 year
Secondary Outcomes (7)
Number of days to bone marrow engraftment
1 year
Medication use
1 year
Urinary stress hormones (cortisol and catecholamines)
1 year
Transplant related complications
1 year
Hospital length of stay and re-hospitalizations
1 year
- +2 more secondary outcomes
Study Arms (3)
Usual Care
NO INTERVENTIONNormal standard of care
Nurse education
ACTIVE COMPARATORMeets with oncology nurse
Mindfulness training
EXPERIMENTALTaught Mindfulness meditation
Interventions
Taught mindfulness meditation by mindfulness instructor (trained health care professional/RN) and audio c/d
Meets with oncology nurse to have questions answered about medical treatments and side effects
Eligibility Criteria
You may qualify if:
- Autologous stem cell transplantation for hematologic malignancy
- First transplant
- years of age or older
- Speaks and understands English
You may not qualify if:
- Planned tandem (more than one) transplant
- Taking corticosteroids on a regular basis for a chronic condition
- Prior formal mindfulness meditation training
- Significant cognitive impairment and/or confirmed psychosis or thought disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Dana-Farber Cancer Institutecollaborator
- University of Massachusetts, Worcestercollaborator
Study Sites (3)
Emory University
Atlanta, Georgia, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Bauer-Wu, PhD
Emory University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 14, 2005
Study Start
April 1, 2005
Primary Completion
January 1, 2010
Study Completion
June 1, 2011
Last Updated
November 28, 2013
Record last verified: 2013-11